What happens after you stop taking GLP-1 drugs? While FDA-approved medications are helping people lose weight, they don’t ...

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.

By Tarun Sai Lomte Weight-loss drugs like semaglutide may melt fat, but at the cost of muscle mass. A new review reveals how ...

Significantly lower risks seen for endometrial cancer, ovarian cancer, meningioma; nonsignificantly increased risk seen for kidney cancer.

According to published results, glucagon-like peptide-1 agonists may not be associated with increased complications for patients with diabetes who undergo total hip arthroplasty.Results showed ...

Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted predominantly by intestinal enteroendocrine L cells in response to nutrient ingestion. By enhancing insulin secretion, delaying ...

Glucagon-like-peptide-1 agonists like Ozempic have become extremely popular for weight loss. Here are some of the side effects you should know about.

Glucagon-like peptide-1 receptor (GLP-1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have ...

Glucagon-like peptide-1 receptor agonist use may reduce alcohol consumption and improve outcomes in some individuals.

DALLAS — Glucagon-like peptide-1 receptor agonists may reduce complications after total knee arthroplasty in patients with obesity but who are not diabetic, according to presented results ...